Value of postoperative radiochemotherapy with 5-fluorouracil plus leucovorin in stage IB-IV M0 stomach carcinoma
Hehr, T.; Adamek, H.E.
Strahlentherapie und Onkologie Organ der Deutschen Rontgengesellschaft . 178(3): 164-166
2002
ISSN/ISBN: 0179-7158 PMID: 11962195 Document Number: 548848
Document emailed within 1 workday
Related Documents
Kalofonos, H.P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K.N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G. 2010: Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer Anticancer Research 30(10): 4325-4333Ohtani, H.; Arimoto, Y.; Nishio, K.; Kanamiya, Y.; Oba, H.; Adachi, K.; Shintani, M.; Nakamura, R.; Yui, S. 2008: Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(10): 1769-1774
Yuasa, C.; Okabe, H.; Toko, T.; Takeda, S.; Unemi, N. 1995: Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(13): 1927-1932
Okabo, S.; Arai, T.; Maruyama, S.; Lee, M.; Murase, N.; Tsubaki, M.; Endo, M.; Wada, Y.; Shimoju, K.; Sakurazawa, K.; Sugihara, K.; Maruyama, M.; Yabata, E.; Kawasaki, T.; Sasaki, T. 1997: A randomized comparative study of surgical adjuvant chemotherapy using 5-fluorouracil and dl-leucovorin with CDDP 5-FU and dl-leucovorin for colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(7): 849-854
Baur, M.; Schlappack, O.; Havelec, L.; Mader, R.; Marosi, C.; Scheithauer, W.; Dittrich, C. 1991: 5-Fluorouracil (5-FU)/leucovorin in comparison to other current chemotherapy protocols in metastasizing colorectal carcinoma Wiener Klinische Wochenschrift 103(11): 332-339
Grem, J.L.; Shoemaker, D.D.; Petrelli, N.J.; Douglass, H.O. 1987: Severe and fatal toxic effects observed in treatment with high- and low-dose leucovorin plus 5-fluorouracil for colorectal carcinoma Cancer Treatment Reports 71(11): 1122
Kase, S.; Kubota, T.; Furukawa, T.; Watanabe, M.; Teramoto, T.; Ishibiki, K.; Kitajima, M. 1993: Modulation by 1-leucovorin of 5-fluorouracil antitumor activity on human gastric carcinoma xenograft in nude mouse: preliminary report Nihon Geka Gakkai Zasshi 94(6): 659
Kamnerdsupaphon, P.; Chitapanarux, I.; Lorvidhaya, V.; Sumitsawan, Y.; Tharavichitkul, E.; Sukthomya, V. 2008: Taxotere, cisplatin, fluorouracil, and leucovorin (TPFL)as induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(11): 1869-1873
Yee, L.K.; Allegra, C.J.; Steinberg, S.M.; Grem, J.L. 1992: Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a Journal of the National Cancer Institute 84(23): 1820-1825
Sasaki, T.; Ota, K.; Taguchi, T.; Ogawa, N.; Kurihara, M.; Akazawa, S.; Ogawa, M.; Tominaga, T.; Konishi, T.; Kumai, K. 1995: A randomized early phase Ii study of l-leucovorin and 5-fluorouracil in gastric cancer. l-Leucovorin and 5-FU Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 521-529
Lin, Y.; Chen, J.; Li, J.; Liu, J.; Zhu, K.; Pan, C.; Chen, M.; Pan, J. 2014: Value of postoperative radiochemotherapy for thoracic esophageal squamous cell carcinoma with lymph node metastasis Zhonghua Zhong Liu Za Zhi 36(2): 151-154
Fietkau, R.; Rödel, C. 2000: Postoperative radiochemotherapy of rectal carcinoma reduces the incidence of locoregional recurrences but does not improve the prognosis of patients--the results of a randomized study of the NSABP-R02. National Surgical Adjuvant Breast and Bowel Project Protocol Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(8): 381-382
Kaçar, S.; Varilsüha, C.; Gürkan, A.; Karaca, C. 2008: Pre-operative radiochemotherapy for rectal cancer. A prospective randomized trial comparing pre-operative vs. postoperative radiochemotherapy in rectal cancer patients Acta Chirurgica Belgica 108(5): 518-523
Langhans, P. 1980: The postoperative stomach carcinoma Fortschritte der Medizin 98(30-31): 1173-1177
Allegra, C.J.; Egan, G.F.; Drake, J.C.; Steinberg, S.M.; Swain, S.M. 1988: The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin Advances in Experimental Medicine and Biology 244: 107-112
Aiba, K. 1988: Biochemical modulation of 5-fluorouracil by high-dose leucovorin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 392-408
Bruckner, H.W.; Spigelman, M. 1988: Leucovorin as a clinical potentiator of 5-fluorouracil toxicity and anticancer efficacy Mount Sinai Journal of Medicine new York 55(5): 390-394
Erlichman, C.; Wu, A. 1991: Effects of 5-fluorouracil and leucovorin in spheroids: a model for solid tumours Anticancer Research 11(2): 671-675
Iba, T.; Kidokoro, A.; Fukunaga, M.; Sugiyama, K.; Fukunaga, T.; Aihara, N. 2003: Effect and mechanism of orally administered leucovorin/5-fluorouracil on colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(13): 2077-2081
Tokunaga, Y.; Ryo, J.; Kitaoka, A.; Yagi, T.; Tokuka, A.; Ohsumi, K. 1999: A case of colon cancer recurrence with P-glycoprotein treated by methotrexate, fluorouracil, and leucovorin Hepato-Gastroenterology 46(27): 1736-1739